NCT03630497View on ClinicalTrials.gov

BN201 SAD MAD Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 27, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

February 22, 2019

Conditions
Optic NeuritisOptic; Neuritis, With Demyelination
Interventions
DRUG

Comparison of BN201 treatment with Placebo

Single Dose or Multiple Dose of BN201 IV administration

Trial Locations (1)

CF48 4DR

Simbec Research Limited, Merthyr Tydfil

Sponsors
All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

lead

Accure Therapeutics

INDUSTRY

NCT03630497 - BN201 SAD MAD Study in Healthy Subjects | Biotech Hunter | Biotech Hunter